GSK1733953A
GSK1733953A can be used as a small molecule Mycobacterium tuberculosis respiration inhibitor with an inhibitory effect on MenG activity and an IC50 value of 2.6 ± 0.6 μM.GSK1733953A is a selective biphenylbenzamide with an inhibitory effect on the catalytic methylation of the Mycobacterium tuberculosis desmethylnaphthoquinone methyltransferase, and the MIC of GSK1733953A against Mycobacterium tuberculosis H4Rv was 8.37 μg/ml. MIC of 8.37 μg/ml and MIC of 1.2 to 9.6 μg/ml against drug-resistant strains.GSK1733953A is a candidate compound for the treatment of tuberculosis.
Product Specifications
CAS Number
930470-97-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
385.82
Molecular Formula
C21H17ClFNO3
Notes
Research use only, not for human use.
Receptor
Antibacterial
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
PRKRA, phosphorylated (Ser246) (Interferon-inducible Double Stranded RNA-dependent Protein Kinase Activator A, Protein Kinase, Interferon-inducible Double Stranded RNA-dependent Activator, Protein Activator Of The Interferon-induced Protein Kinase, PKR-associated Protein X, PKR-associating Protein X, HSD14, HSD-14, PACT, RAX) (Azide free) (HRP) discontinued
![Mouse Monoclonal LRRC25 Antibody (OTI1D9) [Alexa Fluor 594]](https://cdn.genprice.uk/genprice/uk/genprice3.webp)
(4- ((3-Acetamidopropyl) amino) butyl) carbamic Acid tert-Butyl Ester
